293 related articles for article (PubMed ID: 10720524)
21. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
Christie CD; Garrison KM; Kiely L; Gupta RK; Heubi J; Marchant CD
Clin Infect Dis; 2001 Oct; 33(7):997-1003. PubMed ID: 11528571
[TBL] [Abstract][Full Text] [Related]
22. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
[TBL] [Abstract][Full Text] [Related]
23. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
Socan M; Prosenc K; Vegnuti M
Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
[TBL] [Abstract][Full Text] [Related]
25. How to make sense of pertussis immunogenicity data.
Olin P; Hallander HO; Gustafsson L; Reizenstein E; Storsaeter J
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S288-91. PubMed ID: 11709761
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
27. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.
Baughman AL; Bisgard KM; Edwards KM; Guris D; Decker MD; Holland K; Meade BD; Lynn F
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1045-53. PubMed ID: 15539504
[TBL] [Abstract][Full Text] [Related]
28. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
29. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
[TBL] [Abstract][Full Text] [Related]
30. Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.
Zackrisson G; Lagergård T; Trollfors B
J Clin Microbiol; 1989 Jul; 27(7):1567-71. PubMed ID: 2768444
[TBL] [Abstract][Full Text] [Related]
31. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
[TBL] [Abstract][Full Text] [Related]
32. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.
von Linstow ML; Pontoppidan PL; von König CH; Cherry JD; Hogh B
Eur J Pediatr; 2010 Sep; 169(9):1119-22. PubMed ID: 20373111
[TBL] [Abstract][Full Text] [Related]
33. Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.
Rappuoli R; Pizza M; De Magistris MT; Podda A; Bugnoli M; Manetti R; Nencioni L
Immunobiology; 1992 Feb; 184(2-3):230-9. PubMed ID: 1587545
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
[TBL] [Abstract][Full Text] [Related]
35. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF
Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995
[TBL] [Abstract][Full Text] [Related]
36. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
37. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
39. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic findings in oral pertussis vaccination].
Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
